| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/04/2001 | CA2377074A1 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 01/04/2001 | CA2376992A1 Use of cpg as an adjuvant for hiv vaccine |
| 01/04/2001 | CA2376923A1 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 01/04/2001 | CA2376922A1 Compounds obtained from salvia species having antiviral activity |
| 01/04/2001 | CA2376914A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | CA2376892A1 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 01/04/2001 | CA2376891A1 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof |
| 01/04/2001 | CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | CA2376785A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors |
| 01/04/2001 | CA2376781A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors |
| 01/04/2001 | CA2376758A1 Hexahydropyrrolo¬1,2-c|pyrimidines as antiviral, antifungal and/or antitumor agents |
| 01/04/2001 | CA2375979A1 An effervescent green tea extract formulation |
| 01/04/2001 | CA2375952A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | CA2370887A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | CA2370517A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/04/2001 | CA2370413A1 Hla binding peptides and their uses |
| 01/04/2001 | CA2365341A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/03/2001 | EP1065213A2 HCV polymerase suitable for crystal structure analysis and method for using the enzyme |
| 01/03/2001 | EP1065212A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 01/03/2001 | EP1064951A2 Erythropoietin derivatives |
| 01/03/2001 | EP1064947A1 In ovo vaccination of 1 type marek's disease virus |
| 01/03/2001 | EP1064942A1 Sustained release preparations |
| 01/03/2001 | EP1064940A1 Antiviral therapy |
| 01/03/2001 | EP1064551A1 Development of human monoclonal antibodies and uses thereof |
| 01/03/2001 | EP1064550A1 AN EQUINE $i(NEOSPORA) ISOLATE AND ITS USES |
| 01/03/2001 | EP1064402A1 Antisense modulation of lfa-3 |
| 01/03/2001 | EP1064366A1 $i(STAPHYLOCOCCUS AUREUS) GENES AND POLYPEPTIDES |
| 01/03/2001 | EP1064358A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 01/03/2001 | EP1064301A1 Bacterial yael family members as targets for antimicrobial drug design |
| 01/03/2001 | EP1064299A1 Cyclohexapeptide wf14573 or its salt, production thereof and use thereof |
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064277A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 01/03/2001 | EP1064273A2 1,3,4-thiadiazoles useful for the treatment of cmv infections |
| 01/03/2001 | EP1064263A2 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 01/03/2001 | EP1064025A2 Combined vaccine compositions |
| 01/03/2001 | EP1064024A1 Vaccines against circovirus infections |
| 01/03/2001 | EP1064022A1 Hla-binding peptides and their uses |
| 01/03/2001 | EP1064018A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/03/2001 | EP1064007A1 nrdG |
| 01/03/2001 | EP1064004A1 Metal/thiol biocides |
| 01/03/2001 | EP1063885A1 Xylitol compositions for treating upper respiratory conditions |
| 01/03/2001 | EP0816506B1 System for the expression of heterologous antigens as fusion proteins |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/03/2001 | CN1278817A S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
| 01/03/2001 | CN1278813A Antimicrobial quinolones, their compositions and uses |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278739A Method of delivering genes to antigen presenting cells of the skin |
| 01/03/2001 | CN1278735A Vaginal suppository vaccine for urogenital infections |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278722A 8a-azalides as veterinary antimicrobial agents for animals |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1060175C Method for prepn. of 3-formyl-cephem derivatives |
| 01/03/2001 | CN1060083C Medicinal bolus for treating pulmonary tuberculosis and method for preparing same |
| 01/03/2001 | CN1060082C Medicine for treating tuberculosis of lymphnode, and method for preparing same |
| 01/03/2001 | CN1060050C Jiawei double coptis medieament and preparing method thereof |
| 01/02/2001 | US6169181 Compounds useful to treat retroviral infections |
| 01/02/2001 | US6169175 Dna sequence encoding a variant m2 polypeptide of influenza a having a deletion of a domain, thus causing a reduction in hydrophobicity and an increase solubility in aqueous buffers |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168943 Methods for making modified recombinant vesiculoviruses |
| 01/02/2001 | US6168942 Attenuated forms of bovine viral diarrhea virus |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168797 FabF |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv |
| 01/02/2001 | US6168784 Block the inflammatory effects of rantes, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, rheumatoid arthritis and hiv infections |
| 01/02/2001 | CA2310896A1 Hcv polymerase suitable for crystal structure analysis and method for using the enzyme |
| 01/02/2001 | CA2154721C 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/02/2001 | CA2095613C Substituted 1, 3-oxathiolanes and substituted 1, 3-dithiolanes with antiviral properties |
| 01/02/2001 | CA2034979C Antibiotic, deoxymulundocandin, a process for its production and its useas medicament |
| 01/02/2001 | CA2013449C Antibacterial 5-alkylquinolonecarboxylic acids |
| 01/02/2001 | CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them |
| 12/28/2000 | WO2000079010A1 Compositions and methods for preventing transepithelial transmission of hiv |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078946A2 Treatment of viral influenza with antisense oligonucleotides |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078812A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | WO2000078797A1 Rufomycin derivatives useful as antibiotics |
| 12/28/2000 | WO2000078773A2 Process for preparing 6-o-alkenyl-substituted erythromycin deriv atives |
| 12/28/2000 | WO2000078772A2 Antibiotic agents |
| 12/28/2000 | WO2000078761A1 Indolyl-benzimidazole antibacterials, and methods of use thereof |
| 12/28/2000 | WO2000078757A1 Inhibitors of il-12 production |
| 12/28/2000 | WO2000078756A1 Thiophene-ethyl thiourea compounds and their use in the treatment of hiv |
| 12/28/2000 | WO2000078755A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
| 12/28/2000 | WO2000078751A2 Compounds for use in treatment of neurological disorders |
| 12/28/2000 | WO2000078748A1 Quinoline derivatives as antibacterials |
| 12/28/2000 | WO2000078746A1 Antiviral agents |
| 12/28/2000 | WO2000078745A2 Crystalline form of (r)-2-[[[3-methyl- 4- (2,2,2,- trifluoroethoxy) -2- pyridinyl] methyl] sulfinyl] -1h-benzimidazole |
| 12/28/2000 | WO2000078744A1 Thiochroman derivatives against neurological disorders |
| 12/28/2000 | WO2000078732A1 Halopyrimidines |
| 12/28/2000 | WO2000078721A1 Phenetyl-thiourea compounds for treating hiv infections |
| 12/28/2000 | WO2000078718A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 12/28/2000 | WO2000078708A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 12/28/2000 | WO2000078345A1 Method for treatment of lyme disease |
| 12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |